Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Simple Flying: Back From The Brink: Thai Airways Restructuring Progressing Well.
https://simpleflying.com/thai-airways-restructuring-plan-progress/
Simple Flying: Thai Airways' Long-Awaited Return To Profitability In 2021.
https://simpleflying.com/thai-airways-results-show-a-return-to-profitability-in-2021/
Thai Airways is back flying to 13 destinations in 10 countries: https://simpleflying.com/thai-airways-international-flights/
Present!
GM all. Good luck this week! $TAWNF
"..... room, room, room, room?...."
TAWNF news Friday GLTA this week!
https://thethaiger.com/news/national/thai-airways-to-offer-international-flights-to-16-destinations-next-month
As am I. Go TAWNF!
Have a great weekend yourself BR. Nice to see you here. Best of luck! $TAWNF
Wahmbulance is on the way. $tawnf
Nice! Thanks for posting.
The huge drop off in volume around noon yesterday tells me she is correct. Good morning all and good luck today. $TAWNF
In for the long haul here. TAWNF$
GM all. You now own a piece of a flagship airline that is NOT in bankruptcy. Think about that before you let the negative Nancy's shake you out today. Thanks for the news soup!
GLTA
Holding all mine. Yawned thru most of that shake. LOL $TAWNF!
https://finance.yahoo.com/quote/TAWNF/community?p=TAWNF
Good morning all. GLTA today! $TAWNF
Good morning. Go TAWNF
Ho-lee chit.. it's going to pass 10 milly in volume in the first 15 minutes. Saaaweeeeet!
Amen
Yahoo Finance: Vystar Introduces RxAir400 UV-C Light Germicidal Air Purifier Extended Life UV Bulb, Wall Mount Option.
https://finance.yahoo.com/news/vystar-introduces-rxair400-uv-c-134700471.html
Thanks hummba. And agreed.. based on what I've seen so far. GLTA!
Anyone think this is a possible short squeeze?
VYST .0303
Crap! So you didn't get any shares yet?! Ah man...
Awesome Amazon review.... Thanks. And...lmao.. that's a great screen name.
You just got your first follow.
True.
$AFTC _____>
Will it ride the SMAs for support here? :)
http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=AFTC&time=4&startdate=1%2F4%2F1999&enddate=4%2F23%2F2018&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=0&lf=1&lf2=4&lf3=0&type=4&style=330&size=4&x=61&y=17&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11
crazy? yes... thank you for asking. and .15 eh? wouldn't the shorties love that. either way GL.
Time to cover? :D
$gale
sigh....oh Debbie
woot! $gale
Galena Biopharma Inc. (NASDAQ:GALE) had its target price reduced by Maxim Group from $2.00 to $1.00 in a research note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Maxim Group’s price objective indicates a potential upside of 116.36% from the stock’s previous close.
A number of large investors have recently modified their holdings of the company. BlackRock Fund Advisors raised its stake in shares of Galena Biopharma by 8.4% in the first quarter. BlackRock Fund Advisors now owns 4,723,617 shares of the biotechnology company’s stock valued at $6,424,000 after buying an additional 366,359 shares during the perio,d. BlackRock Institutional Trust Company N.A. raised its stake in shares of Galena Biopharma by 3.6% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,198,008 shares of the biotechnology company’s stock valued at $5,709,000 after buying an additional 147,585 shares during the period. State Street Corp raised its stake in shares of Galena Biopharma by 1.7% in the first quarter. State Street Corp now owns 2,401,646 shares of the biotechnology company’s stock valued at $3,265,000 after buying an additional 40,524 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Galena Biopharma by 11.2% in the first quarter. Geode Capital Management LLC now owns 1,227,715 shares of the biotechnology company’s stock valued at $1,669,000 after buying an additional 123,736 shares during the period.
Several other brokerages have also recently weighed in on GALE. FBR & Co reiterated a “buy” rating and issued a $5.00 price target on shares of Galena Biopharma in a research report on Thursday, May 12th. Raymond James Financial Inc. cut Galena Biopharma from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 29th. Roth Capital reiterated a “buy” rating and issued a $5.00 price target on shares of Galena Biopharma in a research report on Thursday, June 9th. Zacks Investment Research upgraded Galena Biopharma from a “hold” rating to a “buy” rating and set a $0.50 price target for the company in a research report on Tuesday, July 12th. Finally, Noble Financial reiterated a “buy” rating and issued a $3.50 price target on shares of Galena Biopharma in a research report on Friday, May 13th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $2.39.
Galena Biopharma (NASDAQ:GALE) opened at 0.4622 on Wednesday. The firm’s market cap is $84.05 million. The firm has a 50-day moving average price of $0.75 and a 200-day moving average price of $1.14. Galena Biopharma has a one year low of $0.28 and a one year high of $2.49.
Galena Biopharma (NASDAQ:GALE) last released its earnings results on Tuesday, August 9th. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.11. During the same period in the previous year, the company earned ($0.10) earnings per share. On average, equities analysts expect that Galena Biopharma will post ($0.23) EPS for the current fiscal year.
Galena Biopharma, Inc is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company’s development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302.
Receive News & Ratings for Galena Biopharma Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galena Biopharma Inc. and related companies with our FREE daily email newsletter.
http://baseballnewssource.com/markets/galena-biopharma-inc-gale-pt-lowered-to-1-00-at-maxim-group/65413/
I think I like where you're heading with this. I've been very stealthy on IHub for quite some time now. I used to be one of those frequent posters... Mostly charts... but have since backed off as I do not have time to constantly post. And I choose not to be involved in pumping stocks. But I do still invest and I do still find gems in the charts. I'll give you a bookmark and I will keep tabs on how this is going. glta!
Best,
BC
I think I like where you're heading with this. I've been very stealthy on IHub for quite some time now. I used to be one of those frequent posters... Mostly charts... but have since backed off as I do not have time to constantly post. And I choose not to be involved in pumping stocks. But I do still invest and I do still find gems in the charts. I'll give you a bookmark and I will keep tabs on how this is going. glta!
Best,
BC
Load the dips.... ;)
Once it starts moving it's too late. $FLSR